Price
Financials
Standalone, Rs crore| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 364 | 536 | 414 | 1,101 | 955 | 940 | 866 | 311 | 319 | 400 | 340 | 314 |
| Expenses | 335 | 497 | 410 | 991 | 820 | 801 | 807 | 274 | 289 | 327 | 232 | 249 |
| Operating Profit | 29 | 39 | 5 | 110 | 135 | 138 | 59 | 37 | 30 | 73 | 108 | 65 |
| OPM % | 8% | 7% | 1.1% | 10% | 14% | 15% | 7% | 12% | 9% | 18% | 32% | 21% |
| Other Income | 9 | 30 | 33 | 25 | 38 | 19 | 38 | 31 | 36 | 131 | 52 | 72 |
| Interest | 0 | 1 | 2 | 36 | 11 | 20 | 6 | 4 | 2 | 3 | 2 | 5 |
| Depreciation | 9 | 13 | 9 | 11 | 15 | 18 | 25 | 16 | 17 | 16 | 14 | 13 |
| Profit before tax | 28 | 54 | 27 | 87 | 146 | 120 | 65 | 48 | 47 | 185 | 143 | 120 |
| Tax % | 12% | 16% | 22% | 19% | 21% | 21% | 20% | 15% | 14% | 22% | 22% | 25% |
| Net Profit | 25 | 46 | 21 | 71 | 116 | 95 | 52 | 41 | 41 | 145 | 111 | 90 |
| EPS in Rs | ||||||||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -5% | -18% | -1% | -8% | ||
| Compounded Profit Growth | 7% | 11% | 31% | -20% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | 9% | 8% | 10% | 8% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 407 | 453 | 474 | 545 | 661 | 757 | 809 | 948 | 848 | 993 | 1,104 | 1,194 |
| Borrowings | 39 | 113 | 97 | 108 | 152 | 155 | 143 | 158 | 8 | 120 | 44 | 196 |
| Other Liabilities | 24 | 35 | 26 | 43 | 95 | 71 | 64 | 94 | 147 | 155 | 156 | 153 |
| Total Liabilities | 482 | 613 | 609 | 707 | 920 | 995 | 1,028 | 1,212 | 1,015 | 1,280 | 1,316 | 1,555 |
| Fixed Assets | 110 | 100 | 94 | 107 | 162 | 171 | 253 | 238 | 162 | 148 | 135 | 124 |
| CWIP | 8 | 8 | 18 | 32 | 67 | 89 | 6 | 4 | 0 | 0 | 233 | 234 |
| Investments | 43 | 34 | 25 | 17 | 70 | 234 | 258 | 213 | 338 | 120 | 120 | 120 |
| Other Assets | 321 | 471 | 472 | 551 | 620 | 501 | 511 | 757 | 515 | 1,012 | 828 | 1,078 |
| Total Assets | 482 | 613 | 609 | 707 | 920 | 995 | 1,028 | 1,212 | 1,015 | 1,280 | 1,316 | 1,555 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 120 | 65 | 129 | 201 | 139 | 138 | -9 | |||||
| Cash from Investing Activity | 0 | -128 | 52 | 50 | -355 | -71 | -178 | |||||
| Cash from Financing Activity | 0 | 0 | 11 | -148 | 110 | -78 | 147 | |||||
| Net Cash Flow | 120 | -63 | 191 | 104 | -107 | -10 | -39 | |||||
| Free Cash Flow | 120 | 65 | 117 | 196 | 135 | 134 | -9 | |||||
| CFO/OP | 87% | 110% | 430% | 742% | 245% | 160% | 43% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 111 | 95 | 80 | 50 | 72 | 37 | 43 | 177 | 70 | 80 | 34 | 56 |
| Inventory Days | 36 | 28 | 28 | 26 | 41 | 67 | 96 | 199 | 74 | 122 | 158 | 192 |
| Days Payable | 9 | 11 | 6 | 5 | 24 | 16 | 7 | 20 | 7 | 13 | 17 | 11 |
| Cash Conversion Cycle | 137 | 111 | 102 | 71 | 88 | 88 | 131 | 356 | 137 | 189 | 175 | 238 |
| Working Capital Days | 216 | 158 | 190 | 92 | 110 | 57 | 99 | 210 | 123 | 105 | 20 | -64 |
| ROCE % | 6% | 10% | 5% | 20% | 21% | 16% | 8% | 4% | 5% | 17% | 13% | 10% |
Fundamentals
Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE9.55 %
ROE7.60 %
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)-8%
Compounded Profit Growth (TTM)-20%
Standalone figures.
Profitability
Operating margin (excl. other income)20.76%
Operating margin (incl. other income)43.75%
EBITDA margin43.75%
Pre-tax margin38.09%
Net profit margin28.62%
ROE7.74%
ROCE9.72%
ROA6.26%
ROE, 3-year average11.26%
ROCE, 3-year average13.77%
ROA, 3-year average9.16%
ROE, 5-year average8.56%
ROCE, 5-year average10.25%
ROA, 5-year average6.95%
ROIC (approx.)14.50%
Tax rate24.85%
Other income / net worth5.98%
Growth
Sales growth (latest year)-7.59%
Profit growth (latest year)-19.04%
Sales CAGR, 3 years-0.54%
Sales CAGR, 5 years-18.37%
Profit CAGR, 3 years30.36%
Profit CAGR, 5 years11.55%
Per share
EPS (TTM)Rs 73.93
EPS (latest year)Rs 73.93
EPS, 3-year averageRs 99.75
EPS, 5-year averageRs 73.23
Book value per shareRs 992.60
Sales per shareRs 258.29
Cash flow per shareRs -7.21
Free cash flow per shareRs -7.40
Efficiency
Asset turnover0.20x
Fixed asset turnover2.54x
Inventory turnover2.00x
Inventory days182 days
Debtor days56 days
Debtors turnover6.48x
Creditor days11 days
Cash conversion cycle238 days
Working capital days-64 days
Leverage
Total debtRs 196 Cr
Cash and bankRs 757 Cr
Net debtRs -561 Cr
Debt to equity0.16x
Net debt / EBITDA-4.09x
Interest coverage25.16x
Owners' fund to total sources77.59%
Debt to assets12.59%
Cash flow
Cash from Operating Activity (latest year)Rs -9 Cr
Cash from Investing Activity (latest year)Rs -178 Cr
Cash from Financing Activity (latest year)Rs 147 Cr
Net Cash Flow (latest year)Rs -39 Cr
Free cash flow (latest year)Rs -9 Cr
FCFE (approx.: FCF + change in debt)Rs 143 Cr
Cash from ops / profit, 5 years1.40x
Statement figures
Net sales (TTM)Rs 314 Cr
Net sales (latest year)Rs 314 Cr
Operating profit excl. other income (latest year)Rs 65 Cr
Other income (TTM)Rs 72 Cr
EBITDA (TTM)Rs 137 Cr
PBDT (TTM)Rs 132 Cr
Profit before tax (TTM)Rs 120 Cr
Tax (latest year)Rs 30 Cr
Net profit (TTM)Rs 90 Cr
Net profit (latest year)Rs 90 Cr
Depreciation (TTM)Rs 13 Cr
Interest (TTM)Rs 5 Cr
Cost of goods sold (latest year)Rs 219 Cr
Total expenditure (latest year)Rs 249 Cr
Total income (latest year)Rs 386 Cr
Share capitalRs 12 Cr
ReservesRs 1,194 Cr
Shareholders' fundsRs 1,207 Cr
Total assetsRs 1,555 Cr
Net blockRs 124 Cr
Capital work in progressRs 234 Cr
InvestmentsRs 120 Cr
ReceivablesRs 48 Cr
InventoryRs 110 Cr
Other liabilitiesRs 153 Cr
Shares outstanding (crore)1.22
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 2 of 8| explain | Receivables outrunning sales Receivables grew 54% vs sales -8% in 2020 |
| explain | Debt up, profit down Borrowings up 344% while net profit fell in 2020 |
| look | Inventory outrunning sales Inventory grew 31% vs sales -8% in 2020 |
| look | Profit leans on other income Other income was 60% of pre-tax profit in 2020 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
CompareNo listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Jindal Drugs Pvt Ltd?
Jindal Drugs Pvt Ltd (531230) has a market capitalisation of Rs Cr. at the close.